Small Molecules

Douglas J. Swirsky, CEO of Rexahn Pharmaceuticals, explains his company’s approach to developing more effective cancer treatments.

The inventor of ibuprofen died on January 30, aged 95.

David Walker discusses the threat of bioterrorism and the importance of basic research.

Emergent Biosolutions, has become a multinational biopharma company, despite working in some difficult therapeutic areas including biodefense.

Industry 4.0 is making progress and should encourage the adoption of new technologies.

A new automated chemical synthesis machine aims to remove some of the repetitive processes from a scientist’s day.

The FDA’s Janet Woodcock explains how manufacturing will change in the coming years.

What are the hottest trends and techniques in drug development?

The PRGLAC Task Force hopes to change the landscape for research on pregnant and lactating women.

Including pregnant women in research isn’t as difficult as some might think…